289 related articles for article (PubMed ID: 32506418)
1. Gene editing technology for improving life quality: A dream coming true?
Ramezankhani R; Minaei N; Haddadi M; Torabi S; Hesaraki M; Mirzaei H; Vosough M; Verfaillie CM
Clin Genet; 2021 Jan; 99(1):67-83. PubMed ID: 32506418
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
3. Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
Li H; Yang Y; Hong W; Huang M; Wu M; Zhao X
Signal Transduct Target Ther; 2020 Jan; 5(1):1. PubMed ID: 32296011
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
5. [CRISPR/Cas9 technology in disease research and therapy: a review].
Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
7. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
8. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
9. Application of genome editing technologies to the study and treatment of hematological disease.
Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
[TBL] [Abstract][Full Text] [Related]
10. Gene editing as a promising approach for respiratory diseases.
Bai Y; Liu Y; Su Z; Ma Y; Ren C; Zhao R; Ji HL
J Med Genet; 2018 Mar; 55(3):143-149. PubMed ID: 29301855
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas systems: Challenges and future prospects.
Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing in Translational Medicine: An Inventory.
Dobner J; Ramachandran H; Rossi A
Front Biosci (Landmark Ed); 2022 Aug; 27(8):241. PubMed ID: 36042173
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Delivery Systems for Therapeutic Genome Editing.
Wang L; Li F; Dang L; Liang C; Wang C; He B; Liu J; Li D; Wu X; Xu X; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128905
[TBL] [Abstract][Full Text] [Related]
14. Gene Editing With TALEN and CRISPR/Cas in Rice.
Bi H; Yang B
Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
[TBL] [Abstract][Full Text] [Related]
15. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges.
Ahmad HI; Ahmad MJ; Asif AR; Adnan M; Iqbal MK; Mehmood K; Muhammad SA; Bhuiyan AA; Elokil A; Du X; Zhao C; Liu X; Xie S
Curr Issues Mol Biol; 2018; 28():47-68. PubMed ID: 29428910
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic editing of hepatocyte genome in vivo.
Ruiz de Galarreta M; Lujambio A
J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
19. [Genome-editing: focus on the off-target effects].
He X; Gu F
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
[TBL] [Abstract][Full Text] [Related]
20. TALENs-an indispensable tool in the era of CRISPR: a mini review.
Bhardwaj A; Nain V
J Genet Eng Biotechnol; 2021 Aug; 19(1):125. PubMed ID: 34420096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
